- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06260124
Acute Physiological Effects of Greek Traditional Dancing
April 7, 2024 updated by: Dimitrios Draganidis, University of Thessaly
Acute Effects of Greek Traditional Dancing on Health, Performance and Muscle Damage Markers in Pre- and Postmenopausal Women: Implications of Dancing Tempo.
In Greece, people of different age groups, including young children to older adults, are involved in traditional dance.
To date, the well-know benefits of dancing include entertainment, socialization and increased physical activity.
However, the acute effects of Greek traditional dancing on health, physical performance and muscle damage indices remain largely unknown.
Therefore, the aim of this project is to evaluate the acute effect of Greek traditional dancing on health-, physical performance-, and muscle damage-related parameters by considering the impact of dancing tempo (slow vs moderate vs fast).
In a crossover repeated measures design 10 pre- and 10 post-menopausal women will participate in the three dancing sessions of different tempo in a random order.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
This study aims at determining the acute effect of Greek traditional dancing on health- and physical performance-related parameters by considering the impact of dancing tempo.
Ten pre- and ten postmenopausal women meeting the inclusion criteria will be assigned to a crossover trial.
Initially, participants will undergo baseline testing including (i) anthropometrics, (ii) body composition, (iii) physical performance, (iv) physical activity level and (v) dietary intake.
After baseline measurements, a 7-day familiarization period will take place, during which participants will practice daily on the three experimental dances.
Each dance will be characterized by a different tempo (beats per minute) so that there will be one dance from each tempo category (i.e.
slow, moderate and fast).
After familiarization, participants will execute in a random order the three dancing sessions, on separate days.
Each dancing session will consist of one dance (of either slow or moderate or fast tempo) lasting ~ 3- 4 minutes.
During each dance heart rate, oxygen consumption and activity intensity will be continuously monitored.
Before and immediately after the dance systolic and diastolic blood pressure, perceived exertion and blood lactate will be measure.
In addition, before each dance and at 24 and 48 hours post-dance muscle soreness, muscle strength and resting metabolic rate will be measured and a resting blood sample will be drawn for the assessment of inflammatory and oxidative stress markers.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dimitrios Draganidis, PhD
- Phone Number: 2431047078
- Email: ddraganidis@uth.gr
Study Contact Backup
- Name: Ioannis G Fatouros, PhD
- Phone Number: 2431047047
- Email: ifatouros@uth.gr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Premenopausal and postmenopausal women.
- Abstain from vigorous physical activity and/or exercise during the last (at least) 6 months prior to the study.
- Free of musculoskeletal diseases and injuries.
- Free of cardiometabolic diseases.
- Free of mental health disorders
- No body weight loss >10% over the last 6 months prior to the study
- Non-smokers
Exclusion Criteria:
- Perimenopause and menopause women
- Participation vigorous physical activity and/or exercise during the last (at least) 6 months prior to the study
- Presence of musculoskeletal diseases and injuries.
- Presence of cardiometabolic diseases.
- Presence of mental health disorders
- Body weight loss >10% over the last 6 months prior to the study
- Smokers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre-menopausal women
Pre-menopausal healthy, inactive women that will participate in a random order in three dancing sessions (Greek traditional dancing) of different tempo on non-consecutive days.
|
A single Greek traditional dance of slow tempo lasting 3-4 minutes.
A single Greek traditional dance of moderate tempo lasting 3-4 minutes.
A single Greek traditional dance of fast tempo lasting 3-4 minutes.
|
Experimental: Post-menopausal
Post-menopausal healthy, inactive women that will participate in a random order in three dancing sessions (Greek traditional dancing) of different tempo on non-consecutive days.
|
A single Greek traditional dance of slow tempo lasting 3-4 minutes.
A single Greek traditional dance of moderate tempo lasting 3-4 minutes.
A single Greek traditional dance of fast tempo lasting 3-4 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in blood pressure
Time Frame: At baseline and immediately after the dance
|
Systolic and diastolic blood pressure will be measured using a blood pressure cuff
|
At baseline and immediately after the dance
|
Change in perceived exertion
Time Frame: At baseline and immediately after the dance
|
Perceived exertion will be rated using the Borg Rating of Perceived Exertion scale, a numerical scale that ranges from 6 (no exertion) to 20 (maximum effort).
|
At baseline and immediately after the dance
|
Change in blood lactate
Time Frame: At baseline and immediately after the dance
|
Blood lactate will be measured on a portable, automatic lactate analyser using the relevant strips
|
At baseline and immediately after the dance
|
Change in resting metabolic rate
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Resting metabolic rate (kcal) will be assessed using a portable open-circuit indirect calorimeter with a ventilated hood system
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in delayed-onset of muscle soreness (DOMS)
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
DOMS of the knee extensors and flexors of both limbs will be evaluated by palpation of the relaxed muscle's belly and distal region with participants rating the perceived soreness on a visual analogue scale ranging from 1 to 10.
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in maximal isometric voluntary contraction
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Maximal isometric voluntary contraction of the knee extensors and flexors of both limbs will be assessed using an isokinetic dynamometer.
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in joint range of motion
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Knee joint range of motion will be assessed using a manual goniometer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in functional performance
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Functional performance will be assessed using the movement-based screening tool functional movement screen (FMS)
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in white blood cell count
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
White blood cell count will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in granulocyte count
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Granulocyte count will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in lymphocytes
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Lymphocytes will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in monocytes
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Monocytes will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in creatine kinase concentration
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Creatine kinase will be measured using an automatic blood analyzer and commercially available kits
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in reduced glutathione
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Reduced glutathione will be measured spectrophotometrically in red blood cells
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in oxidized glutathione
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Oxidized glutathione will be measured spectrophotometrically in red blood cells
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in catalase activity
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Catalase activity will be measured spectrophotometrically in red blood cells
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in protein carbonyls
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Protein carbonyls will be measured spectrophotometrically in red blood cells
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in total antioxidant capacity
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Total antioxidant capacity will be measured spectrophotometrically in plasma
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in heart rate
Time Frame: Through dance session completion, an average of 30 minutes
|
Heart rate will be continuously monitored using heart rate sensors
|
Through dance session completion, an average of 30 minutes
|
Change in oxygen consumption
Time Frame: Through dance session completion, an average of 30 minutes
|
Oxygen consumption will be continuously monitored using a portable metabolic system.
|
Through dance session completion, an average of 30 minutes
|
Change in physical activity
Time Frame: Through dance session completion, an average of 30 minutes
|
The number of steps performed will be assessed using an accelerometer (ActiGraph Gt3x)
|
Through dance session completion, an average of 30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in red blood cell count
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Red blood cell count will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in hematocrit
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Hematocrit will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Change in hemoglobin
Time Frame: At baseline and at 24 hours and 48 hours after the dance
|
Hemoglobin will be measured using an automatic blood analyzer
|
At baseline and at 24 hours and 48 hours after the dance
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dimitrios Draganidis, PhD, University of Thessaly, Department of Physical Education and Sport Science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 10, 2024
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
October 30, 2024
Study Registration Dates
First Submitted
January 16, 2024
First Submitted That Met QC Criteria
February 14, 2024
First Posted (Actual)
February 15, 2024
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 7, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Greek Dancing-UTH
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasRecruitingMenopause Related ConditionsUnited States
-
Wake Forest University Health SciencesWithdrawnMenopause Related Conditions
-
I.M. Sechenov First Moscow State Medical UniversityCompletedMenopause Related ConditionsRussian Federation
Clinical Trials on Slow tempo
-
Indiana UniversityNational Institute on Aging (NIA)Active, not recruitingPain | Anxiety | Intensive Care Unit Delirium | Intensive Care Acquired Cognitive ImpairmentUnited States
-
Auburn UniversityCompletedCerebral Palsy | Autism Spectrum Disorder | Down Syndrome | Developmental DisabilityUnited States
-
Association pour le Dépistage Organisé des Cancers...National Cancer Institute, FranceUnknownColorectal CancerFrance
-
Dr. Tarit SahaCompleted
-
University of AarhusInnovation Fund DenmarkRecruitingAthletic PerformanceDenmark
-
Children's Hospital Medical Center, CincinnatiVirginia Commonwealth UniversityCompletedPreterm InfantUnited States
-
Toronto Rehabilitation InstituteHeart and Stroke Foundation of CanadaCompleted
-
Shanghai Zhongshan HospitalUnknownNeoplasms | Lymphoma | Inflammation | Cancer | Infection | Sarcoid | Mass LesionChina
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States